Compatibility /100
51/100
High potentialWhy talk
- Legit.Health likely needs funding for the next round — BILIX (South Korea, Series A, $13.3M raised) can offer investor introductions (inferred from public profile).
- BILIX is based in South Korea (Asia): a landing pad on another continent, both ways.
- BILIX has raised about $13.3M — investor introductions are realistic.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
16.3 / 25 pts
Value flows both ways.
- Legit.Health likely needs funding for the next round — BILIX (South Korea, Series A, $13.3M raised) can offer investor introductions (inferred from public profile).
- BILIX likely needs first paying customers — Legit.Health can offer access to its customer base (inferred from public profile).
Market bridge
11.3 / 45 pts
Distant markets.
- BILIX is based in South Korea (Asia): a landing pad on another continent, both ways.
Customer potential
5.0 / 10 pts
Some customer potential.
- Legit.Health has the customers BILIX is still looking for — a channel Legit.Health can open.
Sector synergy
8.5 / 10 pts
Complementary sectors.
- Complementary sectors: HealthTech × Biotech & life sciences — room for a joint offer or co-selling.
Stage complementarity
10.0 / 10 pts
Strong mentoring / investor-intro potential.
- BILIX has raised about $13.3M — investor introductions are realistic.
- BILIX (Series A) is one step ahead of Legit.Health (Seed) — the freshest playbook for Legit.Health's next round.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Market entry”: Needs ↔ offers 25, Market bridge 45, Customer potential 10, Sector synergy 10, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 52/100 — high from 50, medium from 36.
